• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care
    Get the next $NNDM alert in real time by email

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board.

    Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward.

    Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint Moshe as Interim CEO. Moshe brings a strong combination of Company knowledge, financial expertise and public company leadership experience, and we are confident he is well positioned to lead Nano Dimension during this transition. We look forward to working closely with Moshe and the management team as we evaluate the Company's strategic priorities and opportunities, with a continued focus on maximizing long-term value for all shareholders."

    Moshe Rozenbaum, Interim CEO, commented, "I appreciate the Board’s confidence and am honored to serve as Interim CEO of Nano Dimension. I look forward to working closely with the Board, our leadership team, and employees to ensure continuity across the business. Throughout this process, we remain committed to serving our customers, partners, employees, and shareholders."

    About Moshe Rozenbaum

    Moshe Rozenbaum is an experienced corporate development and capital markets executive with a strong background in corporate strategy, governance, capital allocation, and shareholder engagement. He previously served as Nano Dimension's Vice President of Corporate Development, where he led strategic initiatives and investor engagement. Mr. Rozenbaum currently serves as a member of the Board of Directors and Chair of the Audit Committee of Lifeward Ltd. (NASDAQ:LFWD). Earlier in his career, he served as Chief Financial Officer and Chief Operating Officer of Fluent Trade Technologies and as Head of Business Development at Yedid Capital Management. He is a Certified Public Accountant and holds a bachelor’s degree in accounting from Touro University.

    About Phillip Borenstein

    Philip Borenstein has served as a member of Nano Dimension's Board of Directors since December 2025 and was appointed Chairman of the Board in July 2026. Mr. Borenstein is a Partner and Portfolio Manager at Hamilton Equity Partners LLC and founder and partner of Hamilton EQ Management LLC, where he oversees mergers and acquisitions and portfolio management.

    About Nano Dimension Ltd.

    Nano Dimension Ltd. (NASDAQ:NNDM) has historically delivered advanced digital manufacturing technologies, including serving customers across the defense, aerospace, automotive, electronics and medical device industry segments. For more information, please visit www.nano-di.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding Nano Dimension’s strategic plan, strategic alternatives review process, expectations regarding future announcements and information, expectations regarding future performance, and all other statements other than statements of historical fact that address activities, events or developments that Nano Dimension intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements may be characterized by terminology such as "believe," "project," "expect," "anticipate," "estimate," "forecast," "outlook," "target," "endeavor," "seek," "predict," "intend," "strategy," "plan," "may," "could," "should," "will," "would," "continue," "likely," or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. Such statements are based on management’s beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company’s actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, the Company cautions shareholders that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Nano Dimension’s annual report on Form 10-K for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC") on March 31, 2026, and in any subsequent filings with the SEC.

    Except as otherwise required by law, Nano Dimension undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this communication.

    Contacts:

    Investors:

    Purva Sanariya

    Director, Investor Relations

    ir@nano-di.com

    Media:

    Samuel Manning

    Principal Manager, External Communications

    press@nano-di.com



    Primary Logo

    Get the next $NNDM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NNDM
    $LFWD

    CompanyDatePrice TargetRatingAnalyst
    Lifeward Ltd.
    $LFWD
    2/10/2025$10.00Buy
    Laidlaw
    More analyst ratings

    $NNDM
    $LFWD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Stehlin David covered exercise/tax liability with 24,971 units of Ordinary Shares, decreasing direct ownership by 3% to 737,032 units (SEC Form 4) to satisfy withholding obligation

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    7/14/26 4:15:13 PM ET
    $NNDM
    Electrical Products
    Technology

    Chief Executive Officer Stehlin David covered exercise/tax liability with 19,841 units of Ordinary Shares, decreasing direct ownership by 3% to 762,003 units (SEC Form 4) to satisfy tax liability

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    6/10/26 4:15:18 PM ET
    $NNDM
    Electrical Products
    Technology

    Director Sriubas Andrew was granted 160,000 units of Ordinary Shares, increasing direct ownership by 400% to 200,015 units (SEC Form 4)

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    6/4/26 4:01:49 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    $LFWD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Turk Joseph E Jr bought $10,140 worth of Ordinary Shares (6,000 units at $1.69), increasing direct ownership by 48% to 18,516 units (SEC Form 4)

    4 - Lifeward Ltd. (0001607962) (Issuer)

    12/17/24 8:55:09 AM ET
    $LFWD
    Industrial Specialties
    Health Care

    Director Swinford Michael bought $43,858 worth of Ordinary Shares (21,622 units at $2.03), increasing direct ownership by 50% to 65,040 units (SEC Form 4)

    4 - Lifeward Ltd. (0001607962) (Issuer)

    11/27/24 8:03:53 AM ET
    $LFWD
    Industrial Specialties
    Health Care

    Director Swinford Michael bought $30,899 worth of Ordinary Shares (16,907 units at $1.83), increasing direct ownership by 64% to 43,418 units (SEC Form 4)

    4 - Lifeward Ltd. (0001607962) (Issuer)

    11/26/24 7:07:36 AM ET
    $LFWD
    Industrial Specialties
    Health Care

    $NNDM
    $LFWD
    SEC Filings

    View All

    Nano Dimension Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Changes in Control of Registrant, Submission of Matters to a Vote of Security Holders

    8-K - Nano Dimension Ltd. (0001643303) (Filer)

    7/21/26 4:56:32 PM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form 8-K filed by Nano Dimension Ltd.

    8-K - Nano Dimension Ltd. (0001643303) (Filer)

    7/21/26 4:05:15 PM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form 144 filed by Nano Dimension Ltd.

    144 - Nano Dimension Ltd. (0001643303) (Subject)

    7/14/26 7:54:34 AM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    $LFWD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Laidlaw initiated coverage on Lifeward with a new price target

    Laidlaw initiated coverage of Lifeward with a rating of Buy and set a new price target of $10.00

    2/10/25 7:00:44 AM ET
    $LFWD
    Industrial Specialties
    Health Care

    $NNDM
    $LFWD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company’s Board of Directors

    WALTHAM, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- In connection with the upcoming July 31, 2026, Extraordinary General Meeting of Shareholders (the "July EGM"), Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano," or the "Company") and Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson") today jointly announced a settlement agreement. Under the terms of the agreement executed on July 17, the July EGM will be cancelled. Messrs. Pons, Rosensweig, Sriubas and Stehlin (collectively, the "Departing Directors") resigned from the Board and all their positions at Nano. The directors nominated by Murchinson for the July EGM — Messrs. Fruc

    7/20/26 8:30:00 AM ET
    $NNDM
    Electrical Products
    Technology

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    $NNDM
    $LFWD
    Financials

    Live finance-specific insights

    View All

    Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

    Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That This Morning's Conference Call Offered Shareholders Little Beyond Buzzwords and Provided No Opportunity to Ask Questions Regarding a Transaction That Materially Impacts the Future of the Company Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term

    6/15/26 5:55:00 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

    Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value CreationProposed Combination Would Deploy Nano Dimension's Capital Base and Nasdaq listing into a High-Growth Healthcare AI OpportunityExisting Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension's Shares that Reflects a 20% Premium to Nano Dimension's Estimated Net Cash at ClosingInfinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disea

    6/15/26 7:27:56 AM ET
    $NNDM
    Electrical Products
    Technology

    Murchinson Invites Fellow Nano Dimension Shareholders to an Investor Call to Discuss the Current State of the Company

    It Is Time to Talk About Nano Dimension Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today announced it will host an investor conference call to discuss the Company's so-called strategic review, Chairman Bob Pons' role in the "review process," and other concerns related to the Company's business and corporate governance. After eight months of limited progress and minimal communication from Nano regarding its strategic review, Murchinson believes shareholders deserve a constructive

    5/26/26 5:00:00 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    $LFWD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    11/13/24 11:31:24 AM ET
    $NNDM
    Electrical Products
    Technology

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    10/23/24 8:21:43 PM ET
    $NNDM
    Electrical Products
    Technology

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    10/11/24 4:47:45 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    $LFWD
    Leadership Updates

    Live Leadership Updates

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

    Significant Appreciation in Alpha Tau (NASDAQ:DRTS) Position (up ~$128 Million)Scilex (NASDAQ:SCLX) Loan Substantially RepaidTotal Cash and Assets Build to Approximately $270 Million (as of March 31, 2026, after the $10.5 million dividend paid in January 2026)Oramed to Join the Russell 2000 and Russell 3000 Indexes this weekNEW YORK, June 25, 2026 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) ("Oramed" or the "Company" or "we"), a diversified operating company, today issued the following Letter to Shareholders from its Chief Executive Officer, Nadav Kidron. The letter highlights the Company's addition to the Russell 2000 and Russell 3000 indexes, the substantial repa

    6/25/26 11:35:00 AM ET
    $ORMP
    $DRTS
    $SCLX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Biotechnology: Biological Products (No Diagnostic Substances)